Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sector Perform DCC (CDI) (DCC) by RBC Capital
- Avoid EnSilica (ENSI) by Steve Moore in ShareProphets
- Long Term Buy Scottish Mortgage Inv Trust (SMT) by Charlie Keough in The Motley Fool
- Buy Renew Holdings (RNWH) by Berenberg
- Buy Burford Capital NPV (DI) (BUR) by Berenberg
- Buy Hochschild Mining (HOC) by Canaccord Genuity
- Buy Marston's (MARS) by Shore Capital
- Buy Renew Holdings (RNWH) by Shore Capital
- Buy Zegona Communications (ZEG) by Canaccord Genuity
- Buy On The Beach Group (OTB) by Shore Capital
- Buy Aptitude Software Group (APTD) by Canaccord Genuity
- Strong Buy KEFI Gold and Copper (KEFI) by Tom Winnifrith in ShareProphets
- Avoid Jaywing (JWNG) by Steve Moore in ShareProphets
- Watch Darktrace (DARK) by Oliver Rodzianko in The Motley Fool
- Equal Weight Pennon Group (PNN) by Morgan Stanley
- Overweight BP (BP.) by Morgan Stanley
- Overweight United Utilities Group (UU.) by Morgan Stanley
- Overweight Severn Trent (SVT) by Morgan Stanley
- Neutral Babcock International Group (BAB) by Citi
- Watch Auto Trader Group (AUTO) by Oliver Rodzianko in The Motley Fool
LungLife AI, Inc (DI) (LLAI) Share Price
Health Care Sector
NOTE: This is based on 0 open tips for LungLife AI, Inc (DI) (LLAI)
| Latest Bid : 25.00p | Latest Ask : 26.00p |
| High Today : 25.67p | Low Today : 25.50p |
| This Years High : 123.00p | This Years Low : 19.00p |
| Volume : 0 | MKT Cap : £6.38M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
LungLife AI, Inc (DI) (LLAI) Overview
LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.LungLife AI, Inc (DI) (LLAI) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 25.00p | Latest Ask : 26.00p |
| High Today : 25.67p | Low Today : 25.50p |
| This Years High : 123.00p | This Years Low : 19.00p |
| Volume : 0 | MKT Cap : £6.38M |
LungLife AI, Inc (DI) Overview
LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.